RL

Ravindra Lalchand Kumavat

Active Director Director DIN 08951238
DIN 08951238 First appointment Nov 2020 Primary industry Home Appliances
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravindra Lalchand Kumavat

Data last updated:

Ravindra Lalchand Kumavat is a Director at Xeeona Pharma Private Limited (since 2020). The company operates in Home Appliances.

DIN 08951238
Primary Designation Director
Industry Home Appliances
First Appointment 06 Nov 2020
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Xeeona Pharma Private Limited U52311MH2020PTC349603
Director06 Nov 20202020Active

Board colleagues of Ravindra Lalchand Kumavat

NameDINCompanyDesignation
Ziyaulhaq Sirajulla Khan08951239Xeeona Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Xeeona Pharma Private Limited
Premium access

Shareholding and investment profile for Ravindra Lalchand Kumavat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravindra Lalchand Kumavat

Ravindra Lalchand Kumavat currently holds 1 directorship: Xeeona Pharma Private Limited (Director, since 06 Nov 2020).

Ravindra Lalchand Kumavat was first appointed on 06 Nov 2020 as Director at Xeeona Pharma Private Limited.

The current boards of Ravindra Lalchand Kumavat's companies include Ziyaulhaq Sirajulla Khan (Xeeona Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available